Alpha Cognition (ACOG) Stock: Why It's Up Today
Updated Oct 20, 2026, 1:16 PM ET · intraday price
- Trading at $8.80 as of 1:16 PM ET, +3.53% vs the prior close of $8.50.
- Volume 84.29K shares, 0.6x its 50-day average.
- New SEC filings: 4 (Oct 19, 2026).
- No new insider buys or sales reported since the prior session.
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)
ACOG jumps 3.5% to $8.80. Trading at $8.80 (intraday, 1:16 PM ET), +3.53% vs the prior close of $8.50. Day range $8.45–$8.94, opened at $8.57.
ACOG daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — ACOG jumps 3.5% to $8.80
- Trading at $8.80 (intraday, 1:16 PM ET), +3.53% vs the prior close of $8.50. Day range $8.45–$8.94, opened at $8.57.
- Volume was 84.29K shares, 0.6x its 50-day average of 130.43K.
- Price is -1.9% vs its 50-day average ($8.97) and +24.8% vs its 200-day average ($7.05).
- 52-week range $4.50–$10.14; the current price sits at 76% of that range, 13.2% below the 52-week high.
Oct 19, 2026 — ACOG jumps 3.8% to $8.50
- Closed at $8.50, +3.79% vs the prior close of $8.19. Day range $8.13–$8.62, opened at $8.29.
- Volume was 81.81K shares, 0.6x its 50-day average of 129.41K.
- Price is -5.3% vs its 50-day average ($8.97) and +20.7% vs its 200-day average ($7.04).
- 52-week range $4.50–$10.14; today's close sits at 71% of that range, 16.2% below the 52-week high.
Oct 16, 2026 — ACOG slides 3.1% to $8.19, a 1-month low, 7 down days in a row
- Closed at $8.19, -3.08% vs the prior close of $8.45. Day range $8.05–$8.75, opened at $8.37.
- Volume was 70.41K shares, 0.5x its 50-day average of 128.30K — lighter than usual.
- Price is -8.8% vs its 50-day average ($8.98) and +16.5% vs its 200-day average ($7.03).
- 52-week range $4.50–$10.14; today's close sits at 65% of that range, 19.2% below the 52-week high.
- That makes 7 straight losses.
Oct 15, 2026 — ACOG dips 2.3% to $8.45, 6 down days in a row
- Closed at $8.45, -2.31% vs the prior close of $8.65. Day range $8.15–$8.75, opened at $8.64.
- Volume was 225.50K shares, 1.8x its 50-day average of 125.64K.
- Price is -6.1% vs its 50-day average ($8.99) and +20.3% vs its 200-day average ($7.02).
- 52-week range $4.50–$10.14; today's close sits at 70% of that range, 16.7% below the 52-week high.
- That makes 6 straight losses.
Oct 14, 2026 — ACOG dips 1.7% to $8.65, 5 down days in a row
- Closed at $8.65, -1.70% vs the prior close of $8.80. Day range $8.65–$8.92, opened at $8.69.
- Volume was 73.70K shares, 0.6x its 50-day average of 125.14K — lighter than usual.
- Price is -3.8% vs its 50-day average ($9.00) and +23.3% vs its 200-day average ($7.01).
- 52-week range $4.50–$10.14; today's close sits at 74% of that range, 14.7% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — ACOG dips 0.5% to $8.80, 4 down days in a row
- Closed at $8.80, -0.45% vs the prior close of $8.84. Day range $8.55–$8.90, opened at $8.70.
- Volume was 126.00K shares, 1.0x its 50-day average of 124.04K.
- Price is -2.2% vs its 50-day average ($9.00) and +25.7% vs its 200-day average ($7.00).
- 52-week range $4.50–$10.14; today's close sits at 76% of that range, 13.2% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — ACOG dips 2.2% to $8.84, 3 down days in a row
- Closed at $8.84, -2.21% vs the prior close of $9.04. Day range $8.69–$9.09, opened at $9.04.
- Volume was 48.00K shares, 0.4x its 50-day average of 126.17K — lighter than usual.
- Price is -1.7% vs its 50-day average ($8.99) and +26.5% vs its 200-day average ($6.99).
- 52-week range $4.50–$10.14; today's close sits at 77% of that range, 12.8% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — ACOG ends flat (+0.0%) to $9.04
- Closed at $9.04, +0.00% vs the prior close of $9.04. Day range $8.93–$9.18, opened at $8.93.
- Volume was 20.30K shares, 0.2x its 50-day average of 129.05K — lighter than usual.
- Price is +0.6% vs its 50-day average ($8.98) and +29.6% vs its 200-day average ($6.97).
- 52-week range $4.50–$10.14; today's close sits at 80% of that range, 10.8% below the 52-week high.
Oct 8, 2026 — ACOG ends flat (+0.0%) to $9.04
- Closed at $9.04, +0.00% vs the prior close of $9.04. Day range $8.83–$9.09, opened at $9.02.
- Volume was 94.30K shares, 0.7x its 50-day average of 127.71K.
- Price is +0.7% vs its 50-day average ($8.98) and +29.9% vs its 200-day average ($6.96).
- 52-week range $4.50–$10.14; today's close sits at 80% of that range, 10.8% below the 52-week high.
Oct 7, 2026 — ACOG rises 0.7% to $9.04
- Closed at $9.04, +0.67% vs the prior close of $8.98. Day range $8.90–$9.36, opened at $8.95.
- Volume was 40.40K shares, 0.3x its 50-day average of 129.13K — lighter than usual.
- Price is +0.8% vs its 50-day average ($8.97) and +30.2% vs its 200-day average ($6.94).
- 52-week range $4.50–$10.14; today's close sits at 80% of that range, 10.8% below the 52-week high.
Oct 6, 2026 — ACOG dips 1.9% to $8.98
- Closed at $8.98, -1.86% vs the prior close of $9.15. Day range $8.75–$9.23, opened at $9.15.
- Volume was 87.00K shares, 0.7x its 50-day average of 129.55K.
- Price is +0.2% vs its 50-day average ($8.96) and +29.7% vs its 200-day average ($6.92).
- 52-week range $4.50–$10.14; today's close sits at 79% of that range, 11.4% below the 52-week high.
Oct 5, 2026 — ACOG rises 0.5% to $9.15
- Closed at $9.15, +0.55% vs the prior close of $9.10. Day range $8.90–$9.35, opened at $9.10.
- Volume was 52.60K shares, 0.4x its 50-day average of 129.09K — lighter than usual.
- Price is +2.2% vs its 50-day average ($8.95) and +32.5% vs its 200-day average ($6.90).
- 52-week range $4.50–$10.14; today's close sits at 82% of that range, 9.8% below the 52-week high.
Oct 2, 2026 — ACOG jumps 4.6% to $9.10
- Closed at $9.10, +4.60% vs the prior close of $8.70. Day range $8.69–$9.43, opened at $8.69.
- Volume was 194.50K shares, 1.5x its 50-day average of 132.39K.
- Price is +1.9% vs its 50-day average ($8.93) and +32.2% vs its 200-day average ($6.88).
- 52-week range $4.50–$10.14; today's close sits at 82% of that range, 10.3% below the 52-week high.
ACOG bull case vs bear case (from the data)
- Price is +24.8% vs its 200-day average — above the long-term trend line.
- Insiders made 25 open-market purchases in the last 12 months.
- Price is -1.9% vs its 50-day average — short-term trend is down.
- Latest fiscal-year net income: loss of $20.67M.
- Share count up 34.8% in a year (dilution).
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
ACOG latest news & SEC filings
Every SEC filing by or about ACOG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 19, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Opaleye Management Inc. bought 22,657 shares at $8.43 (≈$190.97K) on Oct 15, 2026; now holds 3,245,611
- Opaleye Management Inc. bought 14,283 shares at $8.23 (≈$117.60K) on Oct 16, 2026; now holds 3,259,894
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Opaleye Management Inc. bought 19,050 shares at $8.69 (≈$165.63K) on Oct 1, 2026; now holds 3,222,954
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Opaleye Management Inc. bought 18,337 shares at $8.57 (≈$157.08K) on Sep 24, 2026; now holds 3,190,478
- Opaleye Management Inc. bought 13,426 shares at $8.47 (≈$113.72K) on Sep 25, 2026; now holds 3,203,904
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Opaleye Management Inc. bought 40,373 shares at $8.70 (≈$351.08K) on Sep 14, 2026; now holds 3,088,596
- Opaleye Management Inc. bought 3,375 shares at $8.54 (≈$28.83K) on Sep 15, 2026; now holds 3,091,971
- Opaleye Management Inc. bought 53,029 shares at $8.57 (≈$454.61K) on Sep 16, 2026; now holds 3,145,000
- Opaleye Management Inc. bought 27,141 shares at $8.40 (≈$227.98K) on Sep 16, 2026; now holds 3,172,141
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wills Robert James bought 10,000 shares at $9.62 (≈$96.20K) on Aug 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $6.09M (prior year $1.66M) (+267.6% vs Jun 30, 2025)
- Net income: -$8.79M (prior year -$13.20M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.40 (prior year -$0.82) (loss narrowed vs Jun 30, 2025)
Aug 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 24, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade ACOG
- Last results release: Mar 26, 2026 (8-K Item 2.02). Previous ones: Aug 13, 2024. Based on that rhythm, the next report is likely around Jun 25, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.98% (largest 4.6%).
- Liquidity: about 93.99K shares (≈$827.11K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $8.80 vs a range of $4.50–$10.14 (76% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Management Inc. Opaleye bought 13,426 shares on Sep 25, 2026.
- Latest filings: 10-Q Aug 13, 2026; 8-K Jun 23, 2026; 10-Q May 14, 2026.
- Share count: 21.78M shares outstanding (Aug 13, 2026), +34.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
ACOG market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 8.57 | 8.94 | 8.45 | 8.80 | 84.29K |
| Oct 19, 2026 | 8.29 | 8.62 | 8.13 | 8.50 | 81.90K |
| Oct 16, 2026 | 8.37 | 8.75 | 8.05 | 8.19 | 70.40K |
| Oct 15, 2026 | 8.64 | 8.75 | 8.15 | 8.45 | 225.50K |
| Oct 14, 2026 | 8.69 | 8.92 | 8.65 | 8.65 | 73.70K |
| Oct 13, 2026 | 8.70 | 8.90 | 8.55 | 8.80 | 126.00K |
| Oct 12, 2026 | 9.04 | 9.09 | 8.69 | 8.84 | 48.00K |
| Oct 9, 2026 | 8.93 | 9.18 | 8.93 | 9.04 | 20.30K |
| Oct 8, 2026 | 9.02 | 9.09 | 8.83 | 9.04 | 94.30K |
| Oct 7, 2026 | 8.95 | 9.36 | 8.90 | 9.04 | 40.40K |
| Oct 6, 2026 | 9.15 | 9.23 | 8.75 | 8.98 | 87.00K |
| Oct 5, 2026 | 9.10 | 9.35 | 8.90 | 9.15 | 52.60K |
| Oct 2, 2026 | 8.69 | 9.43 | 8.69 | 9.10 | 194.50K |
| Oct 1, 2026 | 9.18 | 9.18 | 8.51 | 8.70 | 88.40K |
| Sep 30, 2026 | 8.78 | 9.18 | 8.62 | 9.00 | 147.00K |
| Sep 29, 2026 | 8.71 | 8.96 | 8.49 | 8.71 | 61.40K |
| Sep 28, 2026 | 8.50 | 8.75 | 8.30 | 8.60 | 67.10K |
| Sep 25, 2026 | 8.49 | 8.69 | 8.30 | 8.47 | 116.60K |
| Sep 24, 2026 | 8.44 | 8.88 | 8.31 | 8.57 | 141.40K |
| Sep 23, 2026 | 9.03 | 9.03 | 8.40 | 8.78 | 59.00K |
About Alpha Cognition
Alpha Cognition (ACOG) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in GRAPEVINE, TX. State of incorporation: British Columbia, Canada. Fiscal year ends December 31. SEC CIK 1655923.
ACOG board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Rajeev Kumar Bakshi | Director | Jan 16, 2026 |
| Kenneth Anthony Cawkell | Director | Jan 16, 2026 |
| Leonard Powell Mertz | Director | Jan 16, 2026 |
| Phillip Joseph Mertz | Director | Jan 16, 2026 |
| Michael E. Mcfadden | Chief Executive Officer | Jan 13, 2026 |
| Bethany Sensenig | Director | Apr 17, 2026 |
| Robert James Wills | Director | Aug 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lauren D'Angelo | Chief Operating Officer | May 19, 2026 |
| Henry Huy Du | VP Finance and Accounting | Jan 13, 2026 |
| Michael E. Mcfadden | Chief Executive Officer | Jan 13, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 25, 2026 | Management Inc. Opaleye | Buy | 13,426 | $8.47 |
| Sep 25, 2026 | Management Inc. Opaleye | Buy | 13,426 | $8.47 |
| Sep 25, 2026 | Management Inc. Opaleye | Buy | 13,426 | $8.47 |
| Sep 25, 2026 | Management Inc. Opaleye | Buy | 13,426 | $8.47 |
| Sep 24, 2026 | Management Inc. Opaleye | Buy | 18,337 | $8.57 |
| Sep 24, 2026 | Management Inc. Opaleye | Buy | 18,337 | $8.57 |
| Sep 24, 2026 | Management Inc. Opaleye | Buy | 18,337 | $8.57 |
| Sep 24, 2026 | Management Inc. Opaleye | Buy | 18,337 | $8.57 |
| Sep 16, 2026 | Management Inc. Opaleye | Buy | 27,141 | $8.40 |
| Sep 16, 2026 | Management Inc. Opaleye | Buy | 53,029 | $8.57 |
| Sep 16, 2026 | Management Inc. Opaleye | Buy | 27,141 | $8.40 |
| Sep 16, 2026 | Management Inc. Opaleye | Buy | 53,029 | $8.57 |
| Sep 16, 2026 | Management Inc. Opaleye | Buy | 27,141 | $8.40 |
| Sep 16, 2026 | Management Inc. Opaleye | Buy | 53,029 | $8.57 |
| Sep 16, 2026 | Management Inc. Opaleye | Buy | 27,141 | $8.40 |
ACOG financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $10.22M | $-20.67M | -1.18 | $-20.38M |
| Dec 31, 2024 | — | $-14.79M | -2.04 | $-7.76M |
| Dec 31, 2023 | — | $-13.76M | -3.84 | $-8.80M |
Latest balance sheet: total assets $64.52M, total liabilities $11.56M, cash $41.38M (as of Jun 30, 2026).
ACOG earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Mar 26, 2026 | 8-K Item 2.02 (results) | $5.34 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Biogen (BIIB)Halozyme Therapeutics (HALO)Vaxcyte (PCVX)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on ACOG
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 20, 2026, 1:16 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.